All Research Papers Published In EJC Supplements

Research Article
1
10.1016/s1359-6349(12)00003-1

mRCC management: past, present and future

Jun 01, 2012
EJC Supplements
Manuela Schmidinger + 4 more +4

Research Article
10.1016/s1359-6349(11)70008-8

Case histories: breast cancer

Oct 01, 2011
EJC Supplements
Alessandra Gennari + 2 more +2

Research Article
10.1016/s1359-6349(11)70003-9

Anthracyclines in the adjuvant treatment of breast cancer: state of the art

Oct 01, 2011
EJC Supplements
Monica N Fornier

Abstract
10.1016/j.ejcsup.2011.02.049

P48 Pilot study of targeted therapy with EGFR antibody (nimotuzumab) in patients with unresectable head and neck cancer

Mar 21, 2011
EJC Supplements
W Guo + 4 more +4

Abstract
10.1016/j.ejcsup.2011.02.055

P54 Dosimetric comparison of 18FLT and 18FDG PET-CT in contouring biological tumour volume in thoracic oesophageal carcinoma

Mar 21, 2011
EJC Supplements
D Han + 5 more +5

Abstract
10.1016/j.ejcsup.2011.02.027

P26 Expression of MAGE-A3 and its prognostic value in hepatocellular carcinoma in Asian patients

Mar 21, 2011
EJC Supplements
P Lee + 6 more +6

Abstract
10.1016/j.ejcsup.2011.02.023

P22 Olfactory neuroblastoma – Ramathibodi Hospital experience

Mar 21, 2011
EJC Supplements
S Chompoonuch + 1 more +1

Abstract
2
10.1016/j.ejcsup.2011.02.004

OP3 Cost-effectiveness of epidermal growth-factor receptor mutation testing and first-line treatment with gefitinib for advanced non-small-cell lung cancer

Mar 21, 2011
EJC Supplements
G De Lima Lopes + 5 more +5

Abstract
2
10.1016/s1359-6349(10)72107-8

400 Phase I study of JI-101, a novel oral tyrosine kinase inhibitor that selectively targets EphB4, VEGFR2, and PDGFRβ

Nov 01, 2010
EJC Supplements
M Gordon + 8 more +8

Abstract
1
10.1016/s1359-6349(10)72224-2

517 Combining pemetrexed with temozolomide and TRC102 (methoxyamine) causes synergistic cytotoxicity in melanoma cells

Nov 01, 2010
EJC Supplements
L Liu + 5 more +5